ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

AVDL Avadel Pharmaceuticals PLC

18,82
0,52 (2,84%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Avadel Pharmaceuticals PLC AVDL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,52 2,84% 18,82 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
18,63 17,9137 19,09 18,82 18,30
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202414:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
01.4.202414:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
05.3.202414:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
04.3.202421:51EDGAR2Form 8-K - Current report
04.3.202421:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04.3.202412:35EDGAR2Form 8-K - Current report
04.3.202412:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04.3.202412:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202412:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202412:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202414:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14.2.202413:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202423:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202415:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12.2.202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202414:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
16.1.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202413:20EDGAR2Form 8-K - Current report
08.1.202413:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
29.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202320:54EDGAR2Form 144 - Report of proposed sale of securities
08.11.202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202313:09EDGAR2Form 8-K - Current report
08.11.202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
07.11.202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30.10.202313:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20.10.202314:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05.10.202314:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
02.9.202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.9.202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.8.202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
15.8.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202321:50EDGAR2Form 144 - Report of proposed sale of securities
11.8.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202313:37EDGAR2Form 8-K - Current report
09.8.202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
03.8.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:15EDGAR2Form 8-K - Current report
03.8.202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
03.8.202313:30EDGAR2Form 8-K - Current report
02.8.202314:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20.7.202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock